The MarketWatch News Department was not involved in the creation of this content. Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback